The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancer.
Zhang J, Liu J, Yue Y, Wang L, He Q, Xu S, Li J, Liao Y, Chen Y, Wang S, Xie Y, Zhang B, Bian Y, Dimitrov DS, Yuan Y, Zhu J.
Zhang J, et al. Among authors: zhang b.
J Exp Clin Cancer Res. 2024 Jun 20;43(1):173. doi: 10.1186/s13046-024-03099-4.
J Exp Clin Cancer Res. 2024.
PMID: 38898487
Free PMC article.